Literature DB >> 24933711

Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in Cystic Fibrosis.

R Rivas Caldas1, S Boisramé2.   

Abstract

BACKGROUND: Cystic Fibrosis (CF) is a severe genetic disorder that is common among the Caucasian population. Bacterial respiratory infections are the main cause of morbidity and mortality in CF patients. Pseudomonas aeruginosa is the main pathogen of lower airways (LAW) decline.
METHOD: To understand chronic broncho-pulmonary colonization, a systematic review is conducted. The aim of our article is to identify the pathways of contamination in the upper aero-digestive tract.
RESULTS: A large number of articles report that P. aeruginosa is established first at nasopharyngeal sites. The vast majority of authors agree that the upper aero-digestive tract is the first location of colonization by P. aeruginosa and its presence appears to be predictive of subsequent broncho-pulmonary colonization.
CONCLUSION: This review supports the possible involvement of the nasal and paranasal sinuses and oral cavity as means of contamination.
Copyright © 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic Fibrosis; Mouth; Nasal cavity; Paranasal sinuses; Pseudomonas aeruginosa

Mesh:

Year:  2014        PMID: 24933711     DOI: 10.1016/j.jcf.2014.04.008

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  10 in total

1.  16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients.

Authors:  Sarah K Lucas; Robert Yang; Jordan M Dunitz; Holly C Boyer; Ryan C Hunter
Journal:  J Cyst Fibros       Date:  2017-08-18       Impact factor: 5.482

2.  Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis.

Authors:  Rebeca Passarelli Mantovani; Angela Sandri; Marzia Boaretti; Gloria Burlacchini; Veronica Li Vigni; Mattia Scarazzai; Paola Melotti; Caterina Signoretto; Maria M Lleo
Journal:  ERJ Open Res       Date:  2020-08-25

3.  Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa.

Authors:  Barış Gökalsın; Nüzhet Cenk Sesal
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

4.  Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.

Authors:  Cédric Bernarde; Marlène Keravec; Jérôme Mounier; Stéphanie Gouriou; Gilles Rault; Claude Férec; Georges Barbier; Geneviève Héry-Arnaud
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

5.  Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance.

Authors:  Marco Rusnati; Davide Sala; Alessandro Orro; Antonella Bugatti; Gabriele Trombetti; Elena Cichero; Chiara Urbinati; Margherita Di Somma; Enrico Millo; Luis J V Galietta; Luciano Milanesi; Paola Fossa; Pasqualina D'Ursi
Journal:  Molecules       Date:  2018-01-08       Impact factor: 4.411

6.  Gastric Helicobacter pylori infection perturbs human oral microbiota.

Authors:  Eng-Guan Chua; Ju-Yee Chong; Binit Lamichhane; K Mary Webberley; Barry J Marshall; Michael J Wise; Chin-Yen Tay
Journal:  PeerJ       Date:  2019-01-28       Impact factor: 2.984

7.  Toothbrushes may convey bacteria to the cystic fibrosis lower airways.

Authors:  Rebeca Passarelli Mantovani; Angela Sandri; Marzia Boaretti; Alessandra Grilli; Sonia Volpi; Paola Melotti; Gloria Burlacchini; Maria M Lleò; Caterina Signoretto
Journal:  J Oral Microbiol       Date:  2019-08-07       Impact factor: 5.474

8.  Enhancement of pyocyanin production by subinhibitory concentration of royal jelly in Pseudomonas aeruginosa.

Authors:  Dina Auliya Amly; Puspita Hajardhini; Alma Linggar Jonarta; Heribertus Dedy Kusuma Yulianto; Heni Susilowati
Journal:  F1000Res       Date:  2021-01-11

9.  Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.

Authors:  Marlène Keravec; Jérôme Mounier; Emmanuel Prestat; Sophie Vallet; Janet K Jansson; Gaëtan Burgaud; Sylvain Rosec; Stéphanie Gouriou; Gilles Rault; Emmanuel Coton; Georges Barbier; Geneviève Héry-Arnaud
Journal:  Springerplus       Date:  2015-08-09

Review 10.  Recent Strategic Advances in CFTR Drug Discovery: An Overview.

Authors:  Marco Rusnati; Pasqualina D'Ursi; Nicoletta Pedemonte; Chiara Urbinati; Robert C Ford; Elena Cichero; Matteo Uggeri; Alessandro Orro; Paola Fossa
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.